Comparison Overview
Fresenius Kabi Schweiz

Fresenius Kabi Schweiz
N/A
Last Update: 01/03/2026
Als global tätiges Gesundheitsunternehmen ist Fresenius Kabi «Committed to Life». Unsere Produkte, Technologien und Services werden zur Therapie und Versorgung von kritisch und chronisch kranken Patientinnen und Patienten eingesetzt. Mit mehr als 41'000 Mitarbeitenden i...

Teva Pharmaceuticals
124 Dvora hanevi'a, Tel-Aviv, IL, 6944020
Last Update: 28/03/2026
Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicin...
Compliance Ranges Comparison

Fresenius Kabi Schweiz







Teva Pharmaceuticals






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Fresenius Kabi Schweiz in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Teva Pharmaceuticals in 2026.
Incident History - Fresenius Kabi Schweiz (X = Date, Y = Severity)
Fresenius Kabi Schweiz cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Teva Pharmaceuticals (X = Date, Y = Severity)
Teva Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Fresenius Kabi Schweiz

Teva Pharmaceuticals
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.